How many drugs treat Immune thrombocytopenia?

Drug Landscape tracks 3 marketed treatments for Immune thrombocytopenia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/immune-thrombocytopenia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Immune thrombocytopenia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immune thrombocytopenia (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Immune thrombocytopenia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Vyvgart	EFGARTIGIMOD ALFA	Argenx Bv	Endoglycosidase [EPC]	IgG receptor FcRn large subunit p51	2021-01-01
Tavalisse	FOSTAMATINIB	Rigel Pharms		Receptor-type tyrosine-protein kinase FLT3	2018-01-01
Efgartigimod	Efgartigimod	M. Peter Marinkovich	Endoglycosidase [EPC]	FcRn

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Argenx Bv · 1 drug in Immune thrombocytopenia
M. Peter Marinkovich · 1 drug in Immune thrombocytopenia
Rigel Pharms · 1 drug in Immune thrombocytopenia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Immune thrombocytopenia:

Cite this brief

Drug Landscape (2026). Immune thrombocytopenia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/immune-thrombocytopenia. Accessed 2026-06-10.

Immune thrombocytopenia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing